Obesity and Insulin Resistance

Obesity and insulin resistance are closely linked and contribute to the onset of type 2 diabetes and other metabolic disorders. This session will focus on the mechanisms that connect obesity and insulin resistance, with an emphasis on the latest research into their pathophysiology. Experts will explore how adipose tissue, inflammation, and insulin signaling contribute to the development of metabolic diseases.

Attendees will also learn about current and emerging therapeutic strategies to treat obesity and improve insulin sensitivity, including pharmacological interventions, lifestyle changes, and surgical options. Discussions will cover the challenges in managing these conditions, particularly in populations with high obesity rates, and how healthcare providers can improve treatment outcomes.

    Related Conference of Obesity and Insulin Resistance

    May 08-09, 2025

    5th European Endocrinology and Diabetes Congress

    Madrid, Spain
    May 19-20, 2025

    6th World Summit on Diabetes

    Rome, Italy
    June 04-05, 2025

    4th World Congress on Diabetes and Pediatric Endocrinology

    Edinburgh, Scotland
    July 29-30, 2025

    15th World Congress on Endocrinology and Diabetes

    Paris, France
    September 08-09, 2025

    3rd World congress and Expo on Diabetes

    Frankfurt, Germany
    October 30-31, 2025

    5th Annual Summit on Diabetes and Endocrinology

    Paris, France
    November 06-07, 2025

    8th Annual Meeting on Diabetes and Endocrinology

    Dubai, UAE
    November 20-21, 2025

    21st World Congress on Endocrinology & Diabetes

    Paris, France
    March 26-27, 2026

    7th Global summit on Diabetes and Endocrinology

    Amsterdam, Netherlands

    Obesity and Insulin Resistance Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in